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Natural killer (NK) cells are vital components of the antiviral immune response, but their 
contributions in defense against influenza A virus (IAV) are not well understood. To better 
understand NK cell responses during IAV infections, we examined the magnitude, kinet-
ics, and contribution of NK cells to immunity and protection during high- and low-dose 
IAV infections. Herein, we demonstrate an increased accumulation of NK cells in the lung 
in high-dose vs. low-dose infections. In part, this increase is due to the local proliferation 
of pulmonary NK cells. However, the majority of NK cell accumulation within the lungs 
and airways during an IAV infection is due to recruitment that is partially dependent 
upon CXCR3 and CCR5, respectively. Therefore, altogether, our results demonstrate 
that NK cells are actively recruited to the lungs and airways during IAV infection and 
that the magnitude of the recruitment may relate to the inflammatory environment found 
within the tissues during high- and low-dose IAV infections.
Keywords: natural killer cells, influenza virus, cell trafficking, lung, cXcr3, ccr5
inTrODUcTiOn
Natural killer (NK) cells, innate lymphocytes with cytolytic activity against infected and transformed 
cells, have known roles in protection from DNA virus infections, including members of the herpes-
viridae, poxviridae, and papillomaviridae families (1–3). More recently, NK cells have been shown 
to participate in the immune response against the orthomyxovirus influenza A virus (IAV), whose 
segmented genome is composed of negative sense RNA. However, it is currently less clear as to 
what contribution NK cells play [i.e., protective (4–11) vs. immunopathologic (12, 13)] in immunity 
during IAV infections. While differences in animal models, virus strains, route of infection, and dose 
of virus may explain the discrepancies between protective and immunopathologic effects, overall, 
these studies all suggest that NK cells are a component of normal immunity to IAV.
Natural killer cell-mediated protection from infections requires effective NK  cell recruitment 
to the sites of lymphocyte activation and infection. NK cell recruitment to the liver is critical for 
Abbreviations: BAL, bronchoalveolar lavage; BrdU, bromodeoxyuridine; CFSE, carboxyfluorescein succinimidyl ester; DLN, 
draining lymph node; IAV, influenza A virus; mAb, monoclonal antibody; NK, natural killer; PBS, phosphate buffered saline; 
p.i., post-infection; PT, pertussis toxin.
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the control of both Toxoplasma gondii and murine cytomegalo-
virus, while recruitment to the draining lymph nodes (DLNs) in 
ectromelia virus infection is important for priming an effective 
CD8 T  cell response (14–16). These data suggest that proper 
NK  cell trafficking is important for both the initial control of 
infections at the replication site and the subsequent priming of 
an adaptive immune response against the pathogen. Currently, 
the mechanisms and molecular networks controlling NK  cell 
trafficking and accumulation in the lungs and draining lymphat-
ics during IAV infection remain unclear. In general, NK  cells 
express many chemokine receptors, including CCR2, CCR5, and 
CXCR3 that have been linked to NK cell migration (17). In the 
lung tissue, CCR2 has been shown to be important for NK cell 
recruitment and subsequent protection from invasive Aspergillus 
fumigatus infections (18). While CCR2 has been shown to influ-
ence NK cell accumulation in the IAV-infected airway, its absence 
had no effect on NK  cell recruitment to the IAV-infected lung 
parenchyma (19). This suggests that the mechanism of NK cell 
recruitment may differ between pulmonary infections. CXCR3 
is known to be important in NK cell recruitment to the lung in 
homeostasis, as CXCR3−/− mice have significantly fewer NK cells 
in the lungs than WT mice (20). While NK  cell expression of 
CXCR3 can result in an increased NK cell accumulation in the 
lungs during pulmonary inflammation (20, 21), the importance 
of CXCR3 in recruiting NK cells to the lung during IAV infec-
tion has not yet been determined. In addition to recruitment to 
individual organs, chemokine receptors can localize cells within 
an organ. For example, while CXCR3 expression is important in 
CD8 T cell recruitment to the lung, CCR5 expression on CD8 
T cells is required for the localization of memory CD8 T cells to 
the IAV-infected epithelium (22, 23). While it has been shown 
that CCR5−/− NK cells are better able to proliferate in the IAV-
infected lung compared to those in WT (24), the role of CCR5 in 
NK cell recruitment to and localization within the IAV-infected 
lung has not been directly examined.
As the dose of virus may affect how NK  cells contribute to 
IAV immunity, we herein examined if IAV infection dose alters 
NK cell recruitment to lungs, lung DLNs, and spleen. Given the 
importance of CXCR3 in NK cell homeostasis, and the role of 
CXCR3 and CCR5 in recruiting and localizing CD8 T  cells to 
the lung during IAV infection, we specifically determined if 
CXCR3 and CCR5 are required for NK cell recruitment during 
both high- and low-dose IAV infections. Our results demonstrate 
that while NK cells accumulate in the lung and DLN during both 
high- and low-dose IAV infections, a greater NK cell accumula-
tion occurs in the lungs during high-dose infections and in the 
DLN during low-dose infections. CXCR3 expression on NK cells 
increased NK  cell recruitment to the lungs, and the increased 
NK  cell recruitment in high-dose IAV infections correlated 
with a higher expression of CXCR3 ligands in the lungs. CCR5 
ligands were also upregulated in the lung and correlated with 
an increased recruitment of WT NK  cells to the lung tissue 
and airways compared to CCR5−/− NK  cells. Overall, our data 
suggest that in addition to infection-dependent mechanisms of 
NK cell recruitment to the lung, the severity of infection may also 




Six- to eight-week-old BALB/c and C57Bl/6 mice were purchased 
from the National Cancer Institute (Frederick, MD). BALB.
B6-CT6 (i.e., CT6) mice were obtained from Dr. Anthony Scalzo 
(Nedlands, Australia). CXCR3−/− (B6.129P2-Cxcr3tm1Djen/J), 
CCR5−/- (B6.129P2-Ccr5tm1Kuz/J), and C57Bl/6 CD45.1 (B6.SJL-
Ptprca Pepcb/BoyJ) were obtained from The Jackson Laboratory 
(Bar Harbor, ME, USA) and bred in house. The C57Bl/6 CD45.1 
colony was started prior to 2009 (25). C57BL/6 and C57Bl/6 
CD45.1 mice were bred together to generate the CD45.1+/
CD45.2+ mice used in adoptive transfer experiments. All animals 
were housed, bred, and maintained in the animal care facilities 
at the University of Iowa. All procedures were approved by the 
University of Iowa Animal Care and Use Committee.
influenza Virus infections
Mouse-adapted IAV A/PR/8/34 was grown in the allantoic fluid 
of embryonated chicken eggs as previously described (26). Mice 
were anesthetized with isofluorane and then infected i.n. with 50 
µL of virus diluted in Iscove’s media as indicated. All experiments 
with IAV were undertaken using BLS2/aBLS2 containment.
influenza Virus Titers
Lungs were removed from infected mice at 2, 4, 6, and 8 days post 
infection (p.i.) and homogenized. Viral titers were determined as 
previously described by end point dilution assay and expressed 
as TCIU. Briefly, 10-fold serial dilutions of lung homogenates 
from IAV-infected mice were mixed with 2.5 × 104 Madin–Darby 
canine kidney cells incubated at 37°C. After 24 h, culture super-
natants were removed and fresh media were added to each well. 
After 4 days of incubation, culture supernatants were mixed with 
0.5% chicken RBC and the agglutination pattern was determined, 
and the TCIU values were calculated using the Reed–Muench 
accumulative method.
nK cell Depletion
CT6 mice were administered 300  µg of anti-NK1.1 (PK136) 
monoclonal antibody (mAb) intraperitoneally (i.p.) 2 days before 
and on the day of IAV infection to deplete NK cells. NK depletion 
was verified by flow cytometry using mAbs against NKp46 (clone 
29A1.4) and CD3ε (clone 17A2).
nK cell Purification
Spleens were processed with frosted glass slides to create a 
single-cell suspension. Lymphocytes were separated from red 
blood cells using a Ficoll gradient before NK cells were purified 
using the EasySep Mouse NK Cell Enrichment kit (STEMCELL 
Technologies, Vancouver, Canada) as per manufacturer’s 
instructions. For the competitive trafficking assay WT (CD45.1+/
CD45.2+) and CXCR3−/− or CCR5−/− (CD45.2+) NK  cells were 
mixed 1:1 before transferring 100  µL i.v. to recipient mice 
(CD45.1+) (1–5 × 105 each NK cell population). Mixed donor cells 
were analyzed by flow cytometry prior to injection to determine 
the actual ratio for that individual experiment. Endogenous, 
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transferred WT, and transferred CXCR3−/− or CCR5−/− NK cells 
were identified by CD45.1 and CD45.2 expression by flow cytom-
etry. For calculations of the ratio of donor NK cell trafficking, the 
values observed for each of the donor NK cell populations were 
normalized to the actual input ratio that was observed for the 
mixed donor cells for that experiment.
Flow cytometry
Lungs were digested in DNAse and Collagenase IV for 10 min at 
37°C. Organs were processed through a 60-µm screen, and single-
cell suspensions were blocked in 2% rat serum. The following anti-
bodies were used for these studies: rat anti-mouse CD3ε (17A2), 
hamster anti-mouse CD27 (LG.3A10), rat anti-mouse CD11b 
(M1/70), rat anti-mouse CD49b (DX5), and mouse anti-mouse 
CD45.2 (104) purchased from BD Biosciences (San Jose, CA, USA); 
mouse anti-mouse NK1.1 (PK136) purchased from eBioscience 
(San Diego, CA, USA); and mouse anti-mouse CD45.1 (A20) pur-
chased from Biolegend (San Diego, CA, USA). For surface staining, 
106 cells were incubated with antibody for 25 min at 4°C and then 
fixed in FACS lysis buffer (BD Biosciences, San Jose, CA, USA). All 
flow cytometry data were collected with a BD Canto II and data 
analyzed with Flow Jo software (Tree Star, Inc., Ashland, OR, USA).
nK cell Proliferation assay
For proliferation assays, A/PR/8/34-infected BALB/c mice were 
administered 8  mM carboxyfluorescein succinimidyl ester 
(CFSE) (50 µL) and 2 h later were given 80 µg bromodeoxyur-
idine (BrdU) i.n. as previously described (27). Four hours after 
the BrdU administration, lungs were harvested and single-cell 
suspensions were prepared for flow cytometric analysis with 
anti-CD49b (DX5) and anti-CD3ε mAbs as described above. 
Following cell fixation, BrdU incorporation was determined with 
the BrdU Flow Kit (BD Biosciences San Jose, CA, USA) according 
to manufacturer’s instructions. NK cells proliferating within the 
lung were identified as DX5+CD3−CFSE+BrdU+ cells.
Drug Treatments
For the NK cell trafficking assay, A/PR/8/34-infected BALB/c mice 
were administered 500  ng pertussis toxin (PT) (Sigma-Aldrich, 
St. Louis, MO, USA) in 200 µL phosphate buffered saline (PBS) 
i.p. on days 2, 3, 4, and 5 post IAV infection. For the competitive 
NK  cell trafficking experiment, purified NK  cells from C57Bl/6 
mice (CD45.2+) were incubated with 200 ng/mL PT in RPMI sup-
plemented with 2% FBS for 20 min at 37°C while NK cells from 
C57Bl/6 mice (CD45.1+/CD45.2+) were incubated in media + 2% 
FBS as previously described (28). Cells were washed three times in 
PBS and then mixed at a 1:1 ratio before transfer. Mixed donor cells 
were analyzed by flow cytometry to determine the actual input 
ratio for that individual experiment. For calculations of the ratio of 
donor NK cell trafficking, the values observed for each of the donor 
NK cell populations were normalized to the actual input ratio that 
was observed for the mixed donor cells for that experiment.
elisa
Lungs from A/PR/8/34-infected BALB/c and C57Bl/6 mice were 
harvested at indicated days and were homogenized in 3  mL 
Iscove’s media, aliquoted, and stored at −80°C. DuoSet ELISA 
kits (R&D Systems, Minneapolis, MN, USA) were used to deter-
mine CCL5, CXCL9, CXCL10, and CXCL11 (BALB/c only) per 
manufacturer’s instructions.
resUlTs
nK cells accumulate in the lung and 
lung Dlns During iaV infection
Prior studies examining the contribution of NK cells to IAV immu-
nity have shown disparate results; studies using higher infection 
doses found that NK cells contribute to lethal immunopathology, 
while studies using lower doses of IAV showed a protective role 
for NK cells (4–9, 12, 13). Therefore, to determine if the kinet-
ics and location of NK cell trafficking during IAV infection are 
altered by the severity and initial dose of IAV, BALB/c mice were 
infected with either a high- (1 LD50) or a low (0.1 LD50)-IAV dose, 
and NK cells were subsequently quantified in the lung, lung DLN, 
and spleen by flow cytometry (see Figure 1A for representative 
gating strategy). Following infection, the number of NK  cells 
found in the lung was significantly increased at days 2, 4, 6, and 
8 p.i. in both the high- and low-dose infections when compared 
to naïve mice (day 0) (p < 0.05, Student’s unpaired t-test), with 
maximal accumulation at day 6 p.i. Moreover, NK cell numbers 
in the lung were significantly greater in high- vs. low-dose IAV-
infected lungs on days 4 and 6 p.i. (Figure 1B, left panel). Within 
the DLN, the number of NK cells present was significantly higher 
for IAV-infected mice than in naïve mice at days 2, 4, and 6 p.i. 
NK cell accumulation peaked at day 4 p.i. for both doses of IAV 
(Figure  1B, middle panel). However, while NK  cell accumula-
tion in the lungs was greater in high-dose IAV-infected mice, 
accumulation in the DLN was instead significantly higher for the 
low-dose IAV infection. In the spleen, NK cell numbers initially 
increased at day 2 p.i. before returning to homeostatic levels in 
low-dose IAV-infected mice and were significantly decreased 
relative to naïve mice in high-dose IAV-infected mice (Figure 1B, 
right panel). In summary, similar kinetics of NK cell trafficking 
were observed between high- and low-dose IAV infections; how-
ever, the overall magnitude of NK cell accumulation differed with 
a greater NK  cell accumulation in the lungs during high-dose 
IAV and in the DLN during low-dose IAV infection. Importantly, 
C57Bl/6 mice infected with high and low doses of IAV showed 
similar kinetics and organ preference in NK  cell trafficking as 
BALB/c mice (Figure 1B), suggesting that the pattern of NK cell 
trafficking during IAV infection was not mouse strain-specific.
Natural killer cells can be subdivided into subsets by CD27 
and CD11b expression (CD27+CD11b−, CD27+CD11b+, and 
CD27−CD11b+) to correspond to different stages of maturation 
(29). These NK cell subsets differ in effector molecule expression 
as well as chemokine receptor expression (17, 29, 30). Therefore, 
differential recruitment of the various NK cell subsets could corre-
late with their different roles in immunity (31) or in protection vs. 
immunopathology during IAV infection. When we quantified the 
recruitment of NK cell subsets within the lung, DLN, and spleen 
of high- and low-dose IAV-infected mice, we observed increases 
in all three NK subsets in the lung and DLN. In the lung, mature 
FigUre 1 | Kinetics of natural killer (NK) cell accumulation during high- and low-dose influenza A virus (IAV) infections. (a) Representative gating strategy for 
DX5+CD3− NK cells in the lungs. (B) BALB/c (top) or C57Bl/6 (bottom) mice were infected with a high (1 LD50) or low (0.1 LD50) dose of A/PR/8/34. NK cells were 
enumerated in the lung, lung-draining lymph node (DLN), or spleen at the indicated time points by flow cytometry. Shown are DX5+ or NK1.1+CD3ε− cells. The 
number of NK cells in the DLN is expressed as NK cells per node. (c) NK cells (DX5+CD3ε− gated) within the lung, DLN, and spleen in BALB/c mice were further 
characterized by CD27 and CD11b expression to determine the distribution of functional subsets during both high- (top) and low (bottom)-dose IAV infections. 
Shown are p-values for high- vs. low-dose IAV infections. *p < 0.05, **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). The number of NK cells within 
the lung of high- and low-dose IAV-infected mice was found to be significantly greater than the number of NK cells in naïve lungs at days 2, 4, and 6 p.i. (p < 0.05). 
The decrease in NK cell numbers in the spleen was found to be significantly greater in high-dose-infected mice by two-way ANOVA (p < 0.001). Data are pooled 
from at least two separate experiments, with five mice per time point, per experiment. (D) The fold increase in CD27+CD11b−, CD27+CD11b+, and CD27−CD11b+ 
NK cells within the lungs was calculated by dividing the cell number found with the lungs at the peak of the response by the cell number found within the lungs at 
day 0.
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CD27−CD11b+ NK cells accumulated in the greatest number in 
both the high- and low-dose infections (Figure 1C); however, the 
intermediate CD27+CD11b+ subset showed the greatest relative 
increase in magnitude (Figure 1D). The immature CD27+CD11b− 
NK cells also increased in number within the infected lung, but 
showed no significant difference between high- and low-dose 
infections (p > 0.05) (Figure 1C, left panels), suggesting that the 
CD27+CD11b− NK cell subset did not contribute to the overall 
difference in NK  cell numbers observed in the lungs between 
high- and low-dose IAV infections. Similar to studies utilizing a 
single dose of IAV (32), the accumulation of all three NK subsets 
was also observed in the DLN of both high- and low-dose IAV-
infected mice. NK cell subsets were evenly distributed within the 
DLN, and all NK cell subsets had a maximal accumulation at day 
4 p.i. (Figure 1C, middle panels)—a kinetics which is in excellent 
agreement with those recently reported (31). Unlike what was 
observed in the lung and DLN, where all NK cell subset numbers 
increased within the tissues, only the CD27−CD11b+ NK  cell 
subset had altered kinetics in the spleen during the course of both 
high- and low-dose IAV infection. The number of CD27−CD11b+ 
NK cells decreased in both infection doses (Figure 1C, right pan-
els). Notably, the CD27−CD11b+ subset had the greatest increase 
in the lung, while it had the greatest decrease within the spleen, 
suggesting that NK cell accumulation within the lung during IAV 
infection may be due, in part, to recruitment of this NK cell subset 
from the spleen.
As expected, based on our prior studies (26), despite the dif-
fering accumulation level of NK cells during high- and low-dose 
infections, we observed no differences in IAV virus titers in the 
lungs on day 2, 4, 6, or 8 p.i. (Data Sheet S1 in Supplementary 
Material). Further, when we depleted NK cells from BALB.CT6 
mice (BALB/c mice that express NK1.1), we did not observe 
changes in overall morbidity and mortality (Data Sheet S1 in 
Supplementary Material). This suggests that in the absence of 
NK  cells, or when infection conditions lead to differing mag-
nitudes of NK cell accumulation within lungs (Figure 1), other 
immune cell populations may compensate to control virus loads 
and dictate the outcome of the infection.
nK cell accumulation in the lung During 
iaV infection is not due to apoptosis or 
Proliferation
Since we observed differential trafficking of NK  cells during 
high- and low-dose IAV infections, we next sought to determine 
the mechanism(s) regulating this trafficking. The difference in 
accumulation within the lung between high- and low-dose IAV 
infections could be due to at least three potential mechanisms: 
differential levels of (1) apoptosis, (2) proliferation, and/or 
(3) recruitment. When we examined the level of apoptosis of 
NK cells via active caspase 3/7 and 7-AAD staining, we observed 
that less than 0.5% of the NK  cells were undergoing apoptosis 
(i.e., caspase 3/7+7–AAD+) in either the high- or low-dose 
IAV-infected lungs on day 4 p.i. (not shown). This suggested 
that differential apoptosis likely does not explain the differing 
accumulation of NK cells in the lungs after high- and low-dose 
IAV. Previous studies have examined NK cell proliferation during 
IAV infection and have shown that the main site of NK  cell 
proliferation is the bone marrow, and only a small percentage of 
NK  cells within the lung incorporate BrdU (33, 34). However, 
these studies did not directly differentiate between NK  cells 
proliferating within the lung and NK  cells proliferating in the 
periphery before being recruited to the lung. Further, it remains 
unknown as to what effect the initial dose of IAV has on NK cell 
proliferation. To quantify NK proliferation specifically within the 
lung, we used a CFSE followed by BrdU dual-labeling method 
that we have previously described (27) (Figure 2A). This labeling 
technique utilizes i.n. CFSE administration to tag cells within the 
lungs followed by a subsequent BrdU labeling to identify cells 
that have proliferated within the local lung environment. We 
observed NK cell proliferation in the lung during both high- and 
low-dose infections, which peaked at day 4 p.i. When comparing 
high- to low-IAV infection doses, we observed significantly more 
NK  cells proliferating within the lungs of high-dose-infected 
mice at day 6 p.i. (Figure  2B). While viral dose affected the 
overall number of proliferating NK  cells, similar frequencies 
of proliferating NK  cells were observed between the two virus 
doses (Figure 2C), suggesting that the difference observed in the 
number of proliferating NK cells was reflective of the difference 
in the total number of NK cells recruited to the lungs, rather than 
a direct effect of the initial dose of virus on NK cell proliferation 
itself (Figures 1 and 2C). While our results demonstrate lung-
specific NK cell proliferation for the first time, it should be noted 
that the proportion of NK cells proliferating within the lung is 
very low when compared to IAV-specific T cell proliferation at 
these same time points (Figure 2A) (27). At the peak of NK cell 
proliferation, approximately 2% of NK cells within the lung were 
found to be CFSE+BrdU+, while at the same time point, 55–75% 
of IAV-tetramer+ CD8 T cells (27) and 7–8% of all CD3ε+ T cells 
(Figure 2A) within the lung are CFSE+BrdU+. Finally, although 
we observed NK cell proliferation within IAV-infected lungs, it 
is clear that the number of proliferating NK cells and the associ-
ated cell expansions could not account for the total increase in 
NK cell numbers observed within the lung. These data suggest 
that NK cell recruitment from the periphery into the lung is the 
main contributor to NK cell accumulation observed in both high- 
and low-dose IAV-infected lungs.
nK cells are recruited to the lung  
and Dln via chemokine receptors
As NK cell proliferation within the lung could not account for the 
total NK cell accumulation observed, we next determined if NK cells 
were recruited to the lung during IAV infection via chemokine 
receptors. Chemokine receptors are G protein-coupled receptors 
whose activation is required for gradient-directed recruitment 
of cells into tissues. To determine if chemokine receptors were 
necessary for NK cell accumulation within the IAV-infected lung, 
chemokine receptor activation was blocked by administering PT, 
an inhibitor of G protein-coupled receptors (35), to mice infected 
with either a high or a low dose of IAV. PT significantly decreased 
the number of NK cells in the lungs of both groups of IAV-infected 
mice (Figure 3A). Further, blocking chemokine receptor activa-
tion did not selectively inhibit the recruitment of a specific subset 
FigUre 2 | Small frequency of natural killer (NK) cells proliferate in the lung during low- and high-dose influenza A virus (IAV) infections. BALB/c mice were infected 
with either a high- or low-dose IAV infection and administered carboxyfluorescein succinimidyl ester (CFSE) and bromodeoxyuridine (BrdU) intranasally on the day of 
analysis, as described in Section “Materials and Methods.” (a) Representative flow plots for NK cells (DX5+CD3ε− gated) and T cells (DX5−CD3ε+ gated) in the lungs 
of day 4 or 6 low-IAV dose-infected mice. The (B) number and (c) frequency of proliferating NK cells (i.e., the percentage of all DX5+CD3ε− cells that were also 
CFSE+BrdU+) was determined by flow cytometry. The p-values comparing high- vs. low-dose IAV-infected animals are shown. *p < 0.05 (two-tailed unpaired 
Student’s t-test). Data are pooled from three high-dose experiments and two low-dose experiments, with five mice per group, per time point.
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of NK  cells, as there was no change in the subset distribution 
between PBS- and PT-treated mice (Figure 3B). Notably, while 
PBS-treated mice infected with a high dose of IAV had significantly 
more NK cells in the lungs at day 6 p.i. than low-dose-infected 
mice (Figures 1 and 3A), there was no difference in the number 
of NK cells between high- and low-dose infections in PT-treated 
mice, suggesting that the difference in NK cell accumulation in 
the lung between high- and low-dose infections in non-PT treated 
mice is likely due to enhanced recruitment via chemokine recep-
tors. No difference was observed in NK cell numbers within the 
DLN or spleens between PT- and PBS-treated mice, suggesting 
that the difference in NK cell accumulation observed within the 
lung was due to a decreased trafficking, rather than a toxic effect 
of PT treatment (Figure 3C).
To determine a more specific role for chemokine receptors on 
NK cells in NK cell trafficking during IAV infection, NK cells from 
CD45 congenic mice were incubated with PT (CD45.1−CD45.2+) 
or PBS (CD45.1+CD45.2+) prior to adoptive transfer into IAV-
infected hosts (CD45.1+CD45.2−) (Figure  4A). We observed 
a significant reduction in PT-treated NK  cell trafficking to the 
lung compared to PBS-treated donor NK cells in high-dose IAV-
infected mice at day 4 p.i. and in low-dose IAV-infected mice 
at day 6 p.i. (i.e., lower numerical ratio as a result of a reduced 
recruitment of PT-treated donor cells compared to PBS-treated 
NK  cells, Figure  4B). In contrast to our findings in  vivo in 
PT-treated mice, in  vitro PT-treated NK  cell trafficking to the 
DLN was significantly reduced compared to PBS-treated NK cells 
in both high- and low-dose IAV-infected mice on days 4 and 6 p.i. 
(Figure 4B). The reduced trafficking of PT-treated NK cells into 
the DLN at day 6 p.i. (Figure 4B) suggests that while the overall 
number of NK cells in the DLN is decreasing at that time, there 
is still a detectable influx of NK cells and that trafficking into the 
FigUre 3 | Blockade of chemokine receptor-mediated recruitment results in decreased natural killer (NK) cell accumulation in the influenza A virus (IAV)-infected 
lung. BALB/c mice were infected with either a high or a low dose of IAV and administered a 500 ng/200 μl intraperitoneal injection of pertussis toxin (PT) or 200 µL 
phosphate buffered saline (PBS) on days 2, 3, 4, and 5 post infection (p.i.). On day 6 p.i., lungs (a), draining lymph node (DLN) (per node) (c), and spleens (c) were 
harvested from high-dose-infected mice or low-dose-infected mice, and the number and frequency of NK cells (DX5+CD3ε− gated) were determined by flow 
cytometry. (B) NK cells (DX5+CD3ε− gated) in the lung were further characterized by CD27 and CD11b expression to determine changes in functional NK subset 
distribution. Shown are the p-values comparing PT-treated mice to PBS-treated mice. **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). Data are 
pooled from three high-dose experiments and two low-dose experiments, with five mice per group.
7
Carlin et al. NK Cell Trafficking During IAV
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 781
DLN at later time points is mediated by chemokine receptors. 
No difference in NK cell trafficking to the spleen was observed 
(Figure  4B). These data further support a role for chemokine 
receptor-mediated trafficking of NK cells to the lungs and DLN 
during IAV infection.
cXcr3 expression on nK cells increases 
nK cell recruitment to the lungs and 
Dln of iaV-infected Mice
Since our results implicate chemokine receptors in NK  cell 
accumulation in the lung, we determined which chemokine 
receptors were used for NK cell trafficking to the IAV-infected 
lung. CXCR3 is an important chemokine receptor for NK  cell 
homing in homeostasis (20), and the receptor is used by CD8 
T cells to migrate into the IAV-infected lung (23). Therefore, to 
determine if CXCR3 was necessary for NK  cell recruitment to 
the IAV-infected lung, we again utilized a competitive trafficking 
assay. Donor congenic WT CXCR3+/+ (CD45.1+CD45.2+) and 
CXCR3−/− (CD45.1−CD45.2+) NK  cells were transferred into 
IAV-infected CXCR3+/+ hosts (CD45.1+CD45.2−) (Figure  5A). 
There was a significant decrease in CXCR3−/− NK cell trafficking 
compared to donor WT NK cell trafficking (i.e., KO:WT ratio <1) 
to the lung and DLN in high-dose-infected mice and to the lungs 
FigUre 4 | Inhibition of chemokine receptor signaling in natural killer (NK) cells results in a decreased accumulation in the lungs and draining lymph nodes (DLNs) of 
influenza A virus (IAV)-infected mice. C57Bl/6 (CD45.1) host mice were infected with a high- or low-dose of IAV. 1 × 105 donor C57Bl/6 NK cells treated with 
pertussis toxin (PT) (CD45.2+) and 1 × 105 C57Bl/6 NK cells treated with phosphate buffered saline (PBS) (CD45.1+CD45.2+) were transferred into infected host 
mice for 16–18 h before analysis (i.e., transferred on day 3 p.i. for day 4 analysis, or day 5 p.i. for day 6 analysis). A group of non-NK cell transferred mice was used 
as a control. (a) Representative flow plots for NK cells (NK1.1+CD3ε−) on day 4 p.i. in high-dose IAV lungs, DLN, and spleen showing host (CD45.1+CD45.2−), 
PBS-treated donor (CD45.1+CD45.2+), and PT-treated donor (CD45.1−CD45.2+) NK cells. (B) the normalized ratio of PT-treated NK cells to PBS-treated control 
NK cells in the lungs, DLN, and spleen of infected recipients is shown. Note: equal trafficking between PBS- and PT-treated NK cells = 1, an increased PT-treated 
NK cell trafficking >1, and a decreased PT-treated NK cell trafficking <1. p-values comparing PT-treated NK cell trafficking with PBS-treated cells within the same 
group are shown. #p < 0.05, ###p < 0.001 (two-tailed paired Student’s t-test). *p < 0.05 represents comparison of the PT/PBS ratios between the indicated groups. 
High- and low-dose experiments were performed once with four mice per group.
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of low-dose-infected mice (Figure  5B). Notably, the ratio of 
recruitment of donor CXCR3−/− to CXCR3+/+ NK cell was also 
significantly reduced in high-dose compared to low-dose IAV-
infected mice at day 6 p.i. (Figure 5B), suggesting that CXCR3 
expression on NK cells could be more important for recruitment 
to the lung in high-dose IAV infections. Therefore, the amount of 
CXCR3 ligands, CXCL9, CXCL10, and CXCL11, was quantified 
in the lungs of high- and low-dose-infected mice (Figure 6) to 
determine if differences in ligand expression correlated with 
the differences observed in the competitive trafficking assay 
(Figure 5B). All CXCR3 ligands were significantly increased in 
the lungs of high-dose compared to low-dose-infected BALB/c 
mice at day 2 p.i., while only CXCL11 was expressed in higher 
amounts from days 2 to 6 p.i. (Figure  6A). Similarly, CXCL9 
FigUre 5 | CXCR3 expression by natural killer (NK) cells increases NK cell trafficking to the lung and draining lymph node (DLN) during influenza A virus (IAV) 
infection. C57Bl/6 (CD45.1) host mice were infected with a high or a low dose of IAV. 5 × 105 donor WT C57Bl/6 (CD45.1/CD45.2) and 5 × 105 CXCR3−/− (CD45.2) 
NK cells were transferred into infected host mice for 16–18 h before analysis. (a) Representative flow plots for NK cells (NK1.1+CD3ε−) on day 6 post infection (p.i.) 
in high- or low-dose IAV lungs showing host (CD45.1+CD45.2−), WT donor (CD45.1+CD45.2+), and CXCR3−/− donor (CD45.1−CD45.2+) NK cells. (B) The normalized 
ratio of CXCR3−/− NK cells to WT NK cells in the lungs, DLN, and spleen of infected recipients is shown. Note: equal trafficking between WT and CXCR3−/− 
NK cells = 1. p-values comparing WT to CXCR3−/− NK cell trafficking (two-tailed paired Student’s t-test) within the same group are shown. #p < 0.05, ###p < 0.001, 
and comparing, as indicated, the CXCR3−/− NK cells:WT NK cell ratio between high- and low-dose IAV-infected mice or by time post infection. *p < 0.05, 
***p < 0.001. Data are pooled from two high-dose experiments and three low-dose experiments, with five mice per group.
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and CXCL10 were significantly greater in the lungs of high-dose 
vs. low-dose-infected C57Bl/6 mice at both days 2 and 4 p.i. 
(Figure 6B). The increased amount of CXCR3 ligand found in 
the lungs of mice receiving a high-dose of IAV correlated with 
the reduced CXCR3−/− NK cell trafficking that was observed in 
high-dose IAV-infected mice (Figure 5B).
FigUre 6 | CXCR3 ligands are upregulated in the lungs during influenza A virus (IAV) infection and expressed at higher levels in the lungs of high-dose-infected 
mice. (a) BALB/c and (B) C57Bl/6 mice were infected with either a high- or low-dose IAV. Lungs were homogenized, and the levels of CXCL9, CXCL10, and 
CXCL11 [not expressed (N/A) in C57Bl/6 mice] were quantified by ELISA. p-values comparing chemokine levels in high- vs. low-dose IAV-infected mice are shown. 
*p < 0.05, **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). BALB/c data are pooled from two separate experiments with at least five mice per group. 
C57Bl/6 data are representative of one experiment with at least three mice per group.
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ccr5 localizes nK cells to iaV-infected 
epithelium
While our above studies and others suggest that CXCR3 aids in 
NK  cell recruitment to both the naïve- and IAV-infected lung 
(20), it is not known if or how NK cells are localized to infected 
epithelial cells. Similar to NK cells, CXCR3 expression on CD8 
T cells increases their recruitment to the lung during IAV infec-
tion (23). However, once in the lungs, CCR5 is required for 
FigUre 7 | CCL5 is upregulated in the lungs during high- and low-dose influenza A virus (IAV) infections. (a) BALB/c (left) and C57Bl/6 (right) mice were infected 
with high- and low-dose A/PR/8/34. Lungs were harvested at indicated time points, and CCL5 in supernatants was quantified by ELISA. Uninfected mice were used 
as naïve controls. p-values comparing CCL5 levels in high- vs. low-dose IAV-infected mice are shown. Data were obtained from samples as in Figure 6. (B,c) 
C57Bl/6 (CD45.1) host mice were infected with a high dose of IAV. 3 × 105 donor WT C57Bl/6 (CD45.1/CD45.2) and 3 × 105 CCR5−/− (CD45.2) natural killer (NK) 
cells were transferred into infected host mice for 16–18 h before analysis. (B) Representative flow plots for NK cells (NK1.1+CD3ε−) in the bronchoalveolar lavage 
(BAL) vs. lung tissue showing host (CD45.1+CD45.2−), WT donor (CD45.1+CD45.2+), and CCR5−/− donor (CD45.1−CD45.2+) NK cells. (c) Shown is the normalized 
ratio of CCR5−/− NK cells to WT NK cells in the lungs or BAL fluid of infected recipients. Data are from one experiment with six mice per group. Note: equal 
trafficking between WT and CCR5−/− NK cells = 1. p-values comparing WT to CCR5−/− NK cell trafficking (two-tailed paired Student’s t-test) within the same group 
are shown. ###p < 0.001 and comparing the ratio of CCR5−/−/WT NK cell trafficking in the BAL vs. lung tissue. ***p < 0.001.
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memory CD8 T cell localization to the IAV-infected airway (22). 
Ligands for CCR5 (CCL3, CCL4, and CCL5) are upregulated 
in the lung of both BALB/c and C57Bl/6 mice [Figure 7A (36, 
37)]. Interestingly, while similar trends in CXCR3 ligands were 
observed between BALB/c and C57Bl/6 mice, the pattern of 
relative CCL5 expression appeared to be inverted at later time 
points. While CCL5 was significantly upregulated at day 2 in 
high-dose IAV-infected lungs in both strains, CCL5 continued 
to have a higher expression in high-dose IAV-infected lungs in 
C57Bl/6 mice, while CCL5 expression was significantly higher 
in low-dose IAV-infected BALB/c mice (Figure  7A). Despite 
the difference in expression pattern, CCL5 was significantly 
upregulated in the lungs compared to naïve mice on days 2–8 
during high-dose IAV infection and on days 4–8 during low-
dose IAV infections for both mouse strains (Figure 7A, p < 0.05, 
student’s unpaired t-test). Therefore, we hypothesized that 
CCR5 expression on NK cells would be required for localization 
to the infected epithelium. Previously, it had been shown that 
IAV-infected CCR5−/− mice have less NK  cell accumulation in 
the lung than IAV-infected WT mice (15). However, this defect 
in NK cell recruitment could be due to a requirement for CCR5 
in NK cell recruitment to the IAV-infected lung, or due to the 
known proliferative defects of CCR5−/− NK cells, which results 
in decreased NK  cell numbers in the periphery of naïve mice 
(15). To more directly test if CCR5 was required for NK  cell 
accumulation in the IAV-infected lung, CCR5−/− NK  cells 
(CD45.1−CD45.2+) and WT NK  cells (CD45.1+CD45.2+) were 
adoptively transferred into high-dose IAV-infected WT C57Bl/6 
recipients (CD45.1+CD45.2−) (Figure 7B). A significant decrease 
in the accumulation of CCR5−/− NK  cells compared to WT 
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NK cells in the lung tissue (i.e., ratio <1, Figure 7C) was observed 
at day 6 p.i. To further determine if CCR5 was used for NK cell 
localization within the IAV-infected lungs, CCR5−/− and WT 
NK  cell accumulation within the bronchoalveolar lavage fluid 
was determined. The ability of CCR5−/− NK cells to traffic to the 
IAV-infected airway was significantly reduced compared to WT 
NK cells (Figure 7C), and the ability of CCR5−/− NK cells to traffic 
to the airway was significantly reduced compared to lung tissue, 
suggesting that while CCR5 may aid in NK cell recruitment to 
the lung tissue, it is also important for NK cell localization to the 
infected epithelium.
DiscUssiOn
Our results show that NK cells are actively recruited to the lung 
and lung DLN during IAV infection, consistent with previous 
studies (5). However, herein, we show preferential organ-specific 
recruitment (31, 38, 39) that is dependent on the dose of infection. 
Recruitment to the lung is increased in high-dose IAV infections, 
and accumulation of NK cells within the DLN is increased in low-
dose IAV infections. Importantly, studies have shown disparate 
roles for NK cells in immunity against IAV, with NK cells playing 
a protective role in lower-dose IAV infections and contributing 
to lethal pathology in lethal dose infections (5, 8, 9, 12, 13). While 
the results presented herein argue for differential NK cell recruit-
ment and trafficking based on the IAV infection dose, they also 
suggest that such differences may not alter pulmonary virus titers 
from days 2 to 8 p.i. Furthermore, our results show that the loss 
of NK cells prior to both high- and low-dose IAV infections does 
not alter IAV morbidity or mortality. However, at this time, it is 
difficult to interpret the direct contribution of NK  cells to the 
overall virus control and pathology as compensatory changes in 
other immune cell populations that contribute to these aspects 
occur in the absence of NK  cells or during different infection 
doses. For example, our preliminary studies suggest that IAV-
specific CD4 T cell responses may be increased in the absence 
of NK  cells (not shown). Furthermore, our prior studies have 
demonstrated reduced levels of IAV-specific CD8 T cells in the 
lungs of 1LD50 dose vs. 0.1 LD50 dose IAV-infected mice (26). 
Therefore, future studies determining if the magnitude of the 
NK cell response within the lungs or DLN is a significant con-
tributor to pathology or virus control in both high- and low-dose 
IAV infections will also need to assess the modulation of other 
immune cell populations critical to IAV immunity and pathology 
at the same time.
Herein, we show for the first time that there is a lung-specific 
NK cell proliferation during IAV infection by labeling pulmonary 
cells with CFSE in addition to intranasal BrdU administration. Our 
results are consistent with other studies that administered BrdU 
systemically (33, 34) and in vitro NK cell: alveolar macrophage 
co-cultures (10). Further, we show that NK  cell proliferation 
within the lung is not dependent on IAV virus titers, as the same 
frequency of NK cells proliferated within the lung during both 
high- and low-dose IAV infections. Our findings that NK  cell 
proliferation within the lung does not account for the total accu-
mulation of NK cells and that PT treatment decreases NK cell 
accumulation within the lung suggest that NK cell accumulation 
in the lung is largely due to a directed recruitment rather than a 
local proliferation.
CXCR3 is important for NK cell trafficking to the lung both 
in homeostasis and in bacterial infection (20, 21). Herein, we 
show that CXCR3 also plays a role in recruiting NK cells to the 
lung during IAV infection, as CXCR3−/− NK cells did not traffic 
to the lung as efficiently as WT NK cells. The difference between 
WT and CXCR3−/− NK cell trafficking was more pronounced in 
mice infected with a high-dose IAV infection, and CXCR3 ligands 
were significantly higher in the lungs of high-dose compared 
to low-dose IAV-infected mice. Whether CXCR3 plays a more 
dominant role in NK  cell recruitment during high-dose IAV 
infections or is solely responsible for the increased accumula-
tion of NK  cells within high-dose IAV-infected lungs remains 
to be determined. Importantly, although CXCR3−/− NK  cells 
had significantly reduced recruitment compared to CXCR3+/+ 
NK  cells, CXCR3−/− NK  cells did accumulate in IAV-infected 
lungs. This suggests that the recruitment of NK cells to the lung 
during IAV infection may be multifactorial, most likely utilizing 
several chemokine receptors. Indeed, we have shown herein that 
CCR5 is also used for NK cell recruitment to the IAV-infected 
lung (Figure 7C). CCR5−/− NK cells had impaired accumulation 
to the IAV-infected lung compared to WT NK cells; however, the 
decrease in CCR5−/− NK cell accumulation was not as significant 
as the decrease in CXCR3−/− NK cells accumulation when com-
pared to WT NK cells (Figures 5B and 7C). In addition to CXCR3 
and CCR5, CCR2 is important for NK cell trafficking during IAV 
infection. While others have shown that CCR2 on NK cells does 
not affect accumulation within the IAV-infected lung tissue, it is 
used by NK cells to traffic to the IAV-infected airways (19). It is 
possible that CCR2, among other chemokine receptors, is able to 
compensate for the loss of CXCR3 or CCR5 in NK cell migration 
to the IAV-infected lung.
Our experiments utilizing PT treatment to inhibit NK  cell 
trafficking resulted in opposing findings within the DLN, where 
NK cell accumulation was not affected in PT-treated mice, but 
was significantly inhibited when NK cells were treated with PT 
in vitro. Chemokine receptor signaling is required for both cell 
recruitment to organs and cell egress from organs. CXCR3 has 
been shown to increase NK  cell recruitment to inflammation 
DLNs, while S1P5 and homeostatic chemokines are utilized 
for NK  cell egress from lymph nodes (31, 32, 40, 41). By 
treating mice with PT for 4 days in vivo prior to analysis, we 
likely uncoupled these two processes, and it is not possible to 
determine if the lack of difference observed in NK cell numbers 
in the DLN between in vivo PT and PBS-treated mice is due to 
changes in recruitment to or egress from the lymph node. As 
the adoptive transfer model examines NK cell recruitment for 
16–18 h after transfer, we are more likely to be observing NK cell 
recruitment to the DLN, rather than recruitment and egress. 
While the number of NK cells in the DLN begins to decrease by 
day 6 p.i. (Figure 1B), NK cell recruitment to the DLN could still 
be occurring at day 5 p.i., when PBS- and PT-treated NK cells 
were adoptively transferred to IAV-infected hosts. Finally, 
NK cells in in vivo PT- and PBS-treated mice had been exposed 
to inflammation for 5  days prior to analysis, while in  vitro 
PBS- and PT-treated NK cells were adoptively transferred into 
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IAV-infected hosts and exposed to inflammation for 16–18  h 
before analysis. It is possible that this difference in inflammation 
exposure results in temporal differences in NK cell trafficking. 
Curiously, a recent study has also evaluated the role of CXCR3 in 
the trafficking of NK cells to the DLN during influenza infection 
and found that despite the expression of CXCR3 predominantly 
on the immature CD27+CD11b− subset, the accumulation of 
CXCR3−/− NK  cells in the DLN was largely unaffected (31). 
This result is consistent with our observations during low-dose 
IAV infection (Figure 5). However, during high-dose infection, 
our results suggest a greater importance for CXCR3 in NK cell 
recruitment to the DLN, as CXCR3−/− NK cell recruitment was 
reduced (Figure  5B). Altogether, these results suggest that a 
multifactorial model of chemokine receptor directed recruit-
ment into the DLN where CXCR3 may play a more prominent 
role during high inflammatory or high pathogenic infection 
conditions.
Overall, our data suggest that the severity of IAV infection 
dictates the localization and number of NK cells in lymphoid tis-
sue and the site of infection and that this localization is partially 
dependent on CXCR3 and CCR5 and differential expression of 
CXCR3 and CCR5 ligands.
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